Trials / Sponsors / Nectin Therapeutics Ltd
Nectin Therapeutics Ltd
Industry · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monotherapy and Cancer, Tumor, Solid, Advanced Solid Tumor | Phase 1 | 2022-09-01 |